HEADER TRANSFERASE/TRANSFERASE INHIBITOR 01-APR-17 5VD1 TITLE CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH PHA- TITLE 2 848125 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2- COMPND 3 INHIBITORY KINASE; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 75-362; COMPND 6 SYNONYM: MYT1 KINASE; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PKMYT1, MYT1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)-RIPL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4 KEYWDS KINASE DOMAIN, CELL CYCLE, TYROSINE- AND THREONINE-SPECIFIC KINASE, KEYWDS 2 MEMBRANE-ASSOCIATED PROTEIN KINASE, TRANSFERASE, INHIBITOR, KEYWDS 3 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.-Y.ZHU,E.SCHONBRUNN REVDAT 4 04-OCT-23 5VD1 1 REMARK REVDAT 3 11-DEC-19 5VD1 1 REMARK REVDAT 2 11-OCT-17 5VD1 1 JRNL REVDAT 1 23-AUG-17 5VD1 0 JRNL AUTH J.Y.ZHU,R.A.CUELLAR,N.BERNDT,H.E.LEE,S.H.OLESEN,M.P.MARTIN, JRNL AUTH 2 J.T.JENSEN,G.I.GEORG,E.SCHONBRUNN JRNL TITL STRUCTURAL BASIS OF WEE KINASES FUNCTIONALITY AND JRNL TITL 2 INACTIVATION BY DIVERSE SMALL MOLECULE INHIBITORS. JRNL REF J. MED. CHEM. V. 60 7863 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28792760 JRNL DOI 10.1021/ACS.JMEDCHEM.7B00996 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.01 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 32890 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.147 REMARK 3 FREE R VALUE : 0.194 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.700 REMARK 3 FREE R VALUE TEST SET COUNT : 1217 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 34.0150 - 3.5348 1.00 3749 144 0.1553 0.1764 REMARK 3 2 3.5348 - 2.8061 1.00 3585 137 0.1579 0.2008 REMARK 3 3 2.8061 - 2.4515 1.00 3532 136 0.1488 0.2051 REMARK 3 4 2.4515 - 2.2274 0.99 3523 135 0.1359 0.1965 REMARK 3 5 2.2274 - 2.0678 0.99 3475 134 0.1289 0.1938 REMARK 3 6 2.0678 - 1.9459 0.99 3485 134 0.1295 0.1813 REMARK 3 7 1.9459 - 1.8485 0.98 3426 132 0.1296 0.2089 REMARK 3 8 1.8485 - 1.7680 0.98 3454 132 0.1257 0.2359 REMARK 3 9 1.7680 - 1.6999 0.98 3444 133 0.1305 0.2181 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.150 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 18.760 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.13 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 2396 REMARK 3 ANGLE : 1.405 3245 REMARK 3 CHIRALITY : 0.048 336 REMARK 3 PLANARITY : 0.006 427 REMARK 3 DIHEDRAL : 15.595 898 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5VD1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-APR-17. REMARK 100 THE DEPOSITION ID IS D_1000227248. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-OCT-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : ROSENBAUM-ROCK DOUBLE-CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32890 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 34.008 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 4.480 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.0200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.56 REMARK 200 R MERGE FOR SHELL (I) : 0.30700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.280 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5VCV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14 MG/ML MYT1, 50 MM HEPES PH 7.5, 0.5 REMARK 280 MM DTT, 0.05 M POTASSIUM CHLORIDE, 17.5 (V/V) % PENTAERYTHRITOL REMARK 280 PROPOXYLATE (5/4 PO/OH), 1.5 MM PHA-848125, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.27500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.90500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.69500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 56.90500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.27500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 27.69500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14930 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -23 REMARK 465 HIS A -22 REMARK 465 HIS A -21 REMARK 465 HIS A -20 REMARK 465 HIS A -19 REMARK 465 HIS A -18 REMARK 465 HIS A -17 REMARK 465 SER A -16 REMARK 465 SER A -15 REMARK 465 GLY A -14 REMARK 465 VAL A -13 REMARK 465 ASP A -12 REMARK 465 MET A 74 REMARK 465 HIS A 75 REMARK 465 GLN A 76 REMARK 465 PRO A 362 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A -3 CG CD OE1 NE2 REMARK 470 SER A -2 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HD22 ASN A -7 O HOH A 502 1.34 REMARK 500 O TYR A -5 O HOH A 501 2.14 REMARK 500 O HOH A 519 O HOH A 671 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 233 49.95 -143.82 REMARK 500 ASP A 251 78.86 60.28 REMARK 500 GLU A 265 81.99 -64.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 702 DISTANCE = 6.08 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue P48 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PEG A 402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5VCV RELATED DB: PDB REMARK 900 RELATED ID: 5VCW RELATED DB: PDB REMARK 900 RELATED ID: 5VCX RELATED DB: PDB REMARK 900 RELATED ID: 5VCY RELATED DB: PDB REMARK 900 RELATED ID: 5VCZ RELATED DB: PDB REMARK 900 RELATED ID: 5VD0 RELATED DB: PDB REMARK 900 RELATED ID: 5VD3 RELATED DB: PDB DBREF 5VD1 A 75 362 UNP Q99640 PMYT1_HUMAN 75 362 SEQADV 5VD1 MET A -23 UNP Q99640 INITIATING METHIONINE SEQADV 5VD1 HIS A -22 UNP Q99640 EXPRESSION TAG SEQADV 5VD1 HIS A -21 UNP Q99640 EXPRESSION TAG SEQADV 5VD1 HIS A -20 UNP Q99640 EXPRESSION TAG SEQADV 5VD1 HIS A -19 UNP Q99640 EXPRESSION TAG SEQADV 5VD1 HIS A -18 UNP Q99640 EXPRESSION TAG SEQADV 5VD1 HIS A -17 UNP Q99640 EXPRESSION TAG SEQADV 5VD1 SER A -16 UNP Q99640 EXPRESSION TAG SEQADV 5VD1 SER A -15 UNP Q99640 EXPRESSION TAG SEQADV 5VD1 GLY A -14 UNP Q99640 EXPRESSION TAG SEQADV 5VD1 VAL A -13 UNP Q99640 EXPRESSION TAG SEQADV 5VD1 ASP A -12 UNP Q99640 EXPRESSION TAG SEQADV 5VD1 LEU A -11 UNP Q99640 EXPRESSION TAG SEQADV 5VD1 GLY A -10 UNP Q99640 EXPRESSION TAG SEQADV 5VD1 THR A -9 UNP Q99640 EXPRESSION TAG SEQADV 5VD1 GLU A -8 UNP Q99640 EXPRESSION TAG SEQADV 5VD1 ASN A -7 UNP Q99640 EXPRESSION TAG SEQADV 5VD1 LEU A -6 UNP Q99640 EXPRESSION TAG SEQADV 5VD1 TYR A -5 UNP Q99640 EXPRESSION TAG SEQADV 5VD1 PHE A -4 UNP Q99640 EXPRESSION TAG SEQADV 5VD1 GLN A -3 UNP Q99640 EXPRESSION TAG SEQADV 5VD1 SER A -2 UNP Q99640 EXPRESSION TAG SEQADV 5VD1 MET A 74 UNP Q99640 EXPRESSION TAG SEQRES 1 A 311 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 311 GLY THR GLU ASN LEU TYR PHE GLN SER MET HIS GLN LEU SEQRES 3 A 311 GLN PRO ARG ARG VAL SER PHE ARG GLY GLU ALA SER GLU SEQRES 4 A 311 THR LEU GLN SER PRO GLY TYR ASP PRO SER ARG PRO GLU SEQRES 5 A 311 SER PHE PHE GLN GLN SER PHE GLN ARG LEU SER ARG LEU SEQRES 6 A 311 GLY HIS GLY SER TYR GLY GLU VAL PHE LYS VAL ARG SER SEQRES 7 A 311 LYS GLU ASP GLY ARG LEU TYR ALA VAL LYS ARG SER MET SEQRES 8 A 311 SER PRO PHE ARG GLY PRO LYS ASP ARG ALA ARG LYS LEU SEQRES 9 A 311 ALA GLU VAL GLY SER HIS GLU LYS VAL GLY GLN HIS PRO SEQRES 10 A 311 CYS CYS VAL ARG LEU GLU GLN ALA TRP GLU GLU GLY GLY SEQRES 11 A 311 ILE LEU TYR LEU GLN THR GLU LEU CYS GLY PRO SER LEU SEQRES 12 A 311 GLN GLN HIS CYS GLU ALA TRP GLY ALA SER LEU PRO GLU SEQRES 13 A 311 ALA GLN VAL TRP GLY TYR LEU ARG ASP THR LEU LEU ALA SEQRES 14 A 311 LEU ALA HIS LEU HIS SER GLN GLY LEU VAL HIS LEU ASP SEQRES 15 A 311 VAL LYS PRO ALA ASN ILE PHE LEU GLY PRO ARG GLY ARG SEQRES 16 A 311 CYS LYS LEU GLY ASP PHE GLY LEU LEU VAL GLU LEU GLY SEQRES 17 A 311 THR ALA GLY ALA GLY GLU VAL GLN GLU GLY ASP PRO ARG SEQRES 18 A 311 TYR MET ALA PRO GLU LEU LEU GLN GLY SER TYR GLY THR SEQRES 19 A 311 ALA ALA ASP VAL PHE SER LEU GLY LEU THR ILE LEU GLU SEQRES 20 A 311 VAL ALA CYS ASN MET GLU LEU PRO HIS GLY GLY GLU GLY SEQRES 21 A 311 TRP GLN GLN LEU ARG GLN GLY TYR LEU PRO PRO GLU PHE SEQRES 22 A 311 THR ALA GLY LEU SER SER GLU LEU ARG SER VAL LEU VAL SEQRES 23 A 311 MET MET LEU GLU PRO ASP PRO LYS LEU ARG ALA THR ALA SEQRES 24 A 311 GLU ALA LEU LEU ALA LEU PRO VAL LEU ARG GLN PRO HET P48 A 401 66 HET PEG A 402 17 HETNAM P48 N,1,4,4-TETRAMETHYL-8-{[4-(4-METHYLPIPERAZIN-1-YL) HETNAM 2 P48 PHENYL]AMINO}-4,5-DIHYDRO-1H-PYRAZOLO[4,3- HETNAM 3 P48 H]QUINAZOLINE-3-CARBOXAMIDE HETNAM PEG DI(HYDROXYETHYL)ETHER FORMUL 2 P48 C25 H32 N8 O FORMUL 3 PEG C4 H10 O3 FORMUL 4 HOH *202(H2 O) HELIX 1 AA1 SER A 104 SER A 109 1 6 HELIX 2 AA2 GLY A 147 GLY A 165 1 19 HELIX 3 AA3 SER A 193 GLY A 202 1 10 HELIX 4 AA4 PRO A 206 GLN A 227 1 22 HELIX 5 AA5 LYS A 235 ALA A 237 5 3 HELIX 6 AA6 ASP A 270 MET A 274 5 5 HELIX 7 AA7 ALA A 275 GLY A 281 5 7 HELIX 8 AA8 THR A 285 ASN A 302 1 18 HELIX 9 AA9 GLY A 308 ARG A 316 1 9 HELIX 10 AB1 PRO A 321 ALA A 326 1 6 HELIX 11 AB2 SER A 329 LEU A 340 1 12 HELIX 12 AB3 THR A 349 ALA A 355 1 7 HELIX 13 AB4 LEU A 356 ARG A 360 5 5 SHEET 1 AA1 6 ARG A 80 ARG A 81 0 SHEET 2 AA1 6 LEU A 173 GLU A 179 -1 O GLU A 178 N ARG A 80 SHEET 3 AA1 6 ILE A 182 GLU A 188 -1 O TYR A 184 N TRP A 177 SHEET 4 AA1 6 LEU A 135 SER A 141 -1 N ALA A 137 O THR A 187 SHEET 5 AA1 6 GLY A 122 SER A 129 -1 N GLU A 123 O ARG A 140 SHEET 6 AA1 6 PHE A 110 GLY A 119 -1 N GLY A 117 O VAL A 124 SHEET 1 AA2 2 LEU A 229 VAL A 230 0 SHEET 2 AA2 2 VAL A 256 GLU A 257 -1 O VAL A 256 N VAL A 230 SHEET 1 AA3 2 ILE A 239 LEU A 241 0 SHEET 2 AA3 2 CYS A 247 LEU A 249 -1 O LYS A 248 N PHE A 240 CISPEP 1 ALA A 88 SER A 89 0 -0.04 CISPEP 2 ALA A 261 GLY A 262 0 9.10 SITE 1 AC1 12 TYR A 121 VAL A 124 ALA A 137 LYS A 139 SITE 2 AC1 12 THR A 187 GLU A 188 CYS A 190 GLY A 191 SITE 3 AC1 12 GLN A 196 PHE A 240 ASP A 251 HOH A 647 SITE 1 AC2 4 SER A 114 ARG A 115 GLN A 313 HOH A 532 CRYST1 46.550 55.390 113.810 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021482 0.000000 0.000000 0.00000 SCALE2 0.000000 0.018054 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008787 0.00000